Aortic stenosis (AS) is a chronic, progressive valve disease in which, if not treated, the
estimated 5-year survival of severe AS is only 15–50%. 1 The only effective treatment of …

Among the numerous innovative technical developments within cardiology in recent years,
transcatheter aortic valve implantation (TAVI) certainly holds a leading position. Subsequent …

Background Increased exercise capacity favourably influences clinical outcomes after
transcatheter aortic valve implantation. In our SPORT: TAVI randomised pilot trial, eight …

Transcatheter aortic valve implantation (TAVI) improves event-free survival in patients with
severe aortic stenosis, but patients' exercise capacity remains poor after the procedure …

Abstract Funding Acknowledgements Type of funding sources: Public Institution (s). Main
funding source (s): Amsterdam UMC-location AMC Background Physical activity is crucial to …

Background Transcatheter aortic valve implantation (TAVI) is increasingly applied for aortic
stenosis in elderly patients with impaired mobility and reduced quality of life. These patients …

Since the first-in-man transcatheter implantation of a prosthetic aortic valve in 2002
demonstrated the feasibility of a nonsurgical approach to treatment of severe aortic stenosis …

With the ageing population, the number of patients with aortic stenosis is increasing steadily.
1 Many of these elderly patients have co-morbidities and are at increased risk. 2, 3 …

Transcatheter aortic valve implantation (TAVI) is an alternative therapy for symptomatic
severe aortic valve stenosis in high-risk patients with several co-morbidities. We evaluated …

Transcatheter aortic valve implantation (TAVI) is an increasingly widespread percutaneous
intervention of aortic valve replacement (AVR). The target population for TAVI is mainly …